Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Calcipotriene/Betamethasone Foam vs Enstilar in Psoriasis
NCT03731091Phase 3Completed
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Oct 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcipotriol + betamethasone in Psoriasis vulgaris (PV), sponsored by Glenmark Pharmaceuticals. Started Oct 2018; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT03731091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03731091.